| http://www.w3.org/ns/prov#value | - Stephen Ridgewell.But F&P Healthcare chief executive Michael Daniell said yesterday that while his company could not dismiss the new venture, he did not think it warranted alarm bells at this stage, because the GE side of the sleep apnoea market was tiny and there were issues such as the cost to the patient for using such technology.
|
